What the Antitrust Case Against Martin Shkreli Tells Us About the Latest Trends in Antitrust Enforcement and Shareholder Liability

Click here to read the full article online

This article describes the antitrust case against Martin Skrelli and the implications for the antitrust treatment of certain business practices in the pharmaceutical industry, as well as the potential new risk of liability for controlling shareholders.